| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |